Sort
40,608 grants matching “prostate cancer”
Osteogenic Niche Biology in Progression and Endocrine Resistance of Bone Metastases
$488,881David R Rowley · Baylor College Of Medicine · R01 · FY2020 · CA
Osteogenic Niche Biology in Progression and Endocrine Resistance of Bone Metastases
$488,881David R Rowley · Baylor College Of Medicine · R01 · FY2021 · CA
Osteogenic Niche Biology in Progression and Endocrine Resistance of Bone Metastases
$488,881David R Rowley · Baylor College Of Medicine · R01 · FY2018 · CA
Project 1
$488,873Kristen S. Purrington · Wayne State University · P01 · FY2024 · CA
avb6-directed molecular imaging and therapy
$488,662Julie L Sutcliffe · University Of California At Davis · R01 · FY2018 · CA
avb6-directed molecular imaging and therapy
$488,662Julie L Sutcliffe · University Of California At Davis · R01 · FY2017 · CA
The Evaluation of Novel Therapeutics for Genitourinary Malignancies
$488,637William Laurence Dahut · Division Of Clinical Sciences - Nci · ZIA · FY2020 · CA
Molecular Mechanisms of Large Oncosome-Induced Prostate Cancer Progression and Metastasis
$488,621Dolores Di Vizio · Cedars-Sinai Medical Center · R01 · FY2020 · CA
Canine models for characterization, diagnosis, and treatment of human cancers using comparative canine-human transcriptomics
$488,591Gregory Tawa · National Center For Advancing Translational Sciences · ZIA · FY2019 · TR
Facilitated Education and Testing in BRCA Positive Families
$488,582Marc D Schwartz · Georgetown University · R01 · FY2019 · CA
Androgen Activation of Innate Immune Signaling to Enhance Prostate Cancer Immune Response
$488,578Sushant Krishna Kachhap · Johns Hopkins University · R01 · FY2023 · CA
Development of a Molecular Targeting Agent for PSMA to Diagnose Metastatic Prosta
$488,453James F Kronauge · Molecular Insight Pharmaceuticals, Inc. · R44 · FY2009 · CA
Utilizing genetic and functional strategies to identify causal genes and alleles
$488,427Matthew L Freedman · Dana-Farber Cancer Inst · R01 · FY2016 · GM
Overcoming vaccine-associated hypoxia with advanced biomaterials to enhance cancer immunotherapy
$488,344Sidi A Bencherif · Northeastern University · R01 · FY2021 · EB
TECHNETIUM AND RHENIUM IN NUCLEAR MEDICINE
$488,230Harvard University (Medical School) · R01 · FY2000 · CA
Informed Decision Making Regarding PSA Screening
$488,130University Of California Los Angeles · R01 · FY2005 · CA
Volumetric Perfusion MRI of Liver Tumors to Detect Early Response to Chemotherapy
$488,120Scott B. Reeder · University Of Wisconsin-Madison · RC1 · FY2009 · EB
MR Guided Focused Ultrasound Surgery for Prostate Cancer
$488,106Clare M Tempany · Brigham And Women'S Hospital · R01 · FY2007 · CA
Rapid and flexible precision oncology mouse models of epithelial malignancies epithelial malignancies
$488,090Scott W Lowe · Sloan-Kettering Inst Can Research · R01 · FY2021 · CA
Rapid and flexible precision oncology mouse models of epithelial malignancies epithelial malignancies
$488,090Scott W Lowe · Sloan-Kettering Inst Can Research · R01 · FY2020 · CA
Electrical Property Based Image-guided Prostate Biopsy
$488,070Ryan Joseph Halter · Dartmouth College · RC1 · FY2009 · EB
Community Outreach and Engagement
$488,035Carmen E Guerra · University Of Pennsylvania · P30 · FY2023 · CA
Protein kinase C signaling in prostate cancer health disparities
$488,027Marcelo Gabriel Kazanietz · University Of Pennsylvania · R01 · FY2023 · CA
Geostatistical software for spatial and multi-dimensional joinpoint regression analysis of time series of health outcomes
$487,982Pierre E Goovaerts · Biomedware · R44 · FY2019 · CA
PET Imaging of Cancer with pH (Low) Insertion Peptide (pHLIP)
$487,937Jason S Lewis · Sloan-Kettering Inst Can Research · R01 · FY2010 · CA